Prionics Nominated as a Best in Class Animal Health Company

    ZURICH, Switzerland, October 13 /PRNewswire/ -- Prionics, the world
 leader in BSE and prion testing, has been recognized for its contribution
 to animal health and food safety. After being awarded with the European
 Biotech Award 2004, the nomination for the Animal Pharm Industry Awards
 honors the achievements of the Swiss biotech company in successfully
 expanding its solution portfolio for the early diagnosis of major farm
 animal diseases. Today, Prionics ranks among the top three global companies
 in farm animal diagnostics.
     The first Animal Pharm Industry Excellence Awards
 (www.animalpharmawards.com) held in London on October 12, 2006, has
 identified best in class companies across the animal health industries. The
 prize honors outstanding achievements, judging innovation, performance,
 product pipeline, new drug launches and financial return. "Being considered
 to be among the three best in class animal health companies of the world
 and ranking on a level with renowned companies such as Pfizer Animal Health
 is a tremendous honour for Prionics. It confirms that our strategy to focus
 on major farm animal health issues and grow our diagnostic portfolio
 accordingly is working and that our solutions deliver a competitive edge in
 the market", says Dr Markus Moser, CEO of Prionics.
     Prionics Among Top 3 Global Players
     Food safety by eliminating diseases early in the food chain is growing
 in importance and market potential as it directly affects disease
 prevention in human health management. Within ten years of being formed,
 Prionics ranks among the three leading global diagnostic players in farm
 animal health. The Swiss biotech company intends to further develop its
 core business by creating diagnostic solutions in its own R&D facilities
 and laboratories in Zurich as well as through collaborations and
 acquisitions.
     Building on an extensive scientific network with leading research
 institutes around the world, earlier this year Prionics acquired CEDI
 Diagnostics B.V. and signed a strategic partnership with the Animal Science
 Group of Wageningen (Netherlands), a recognized leader in animal disease
 control. With these latest moves the company has further expanded its
 portfolio with tests proven on the market and gained access to a unique
 research and competence centre.
     About Prionics
     Prionics is the world leader in the diagnosis of BSE and other prion
 diseases. Founded in 1997 as a spin-off from Zurich University and
 headquartered in Zurich, Prionics develops and markets diagnostic products
 for the early diagnosis of farm animal diseases. The company places its
 main focus on diseases which are transmissible from animals to human beings
 and thereby contributing to an improvement to food safety. In October 2005
 Prionics acquired Pfizer Animal Health's Diagnostic portfolio. The
 recipient of the Swiss Economic Award 2002 as "Company of the year" and
 winner of the European Biotech Award 2004 for Excellence in Biotech
 Business; Prionics is driving its business through a combination of
 outstanding research, high-quality products and innovative market
 solutions.
     For more information please visit www.prionics.com/media or contact:
 
     Markus Abt
     Head of Corporate Communications
     Phone: +41-44-200-20-95
     Mobile: +41-79-352-53-16
     Email: media@prionics.com
 
 

SOURCE Prionics AG